Document is current
Any future updates will be listed below
-
Authors
Gwaltney, Chad https://orcid.org/0000-0001-8130-2024
Shields, Alan
Love, Emily
Ollis, Sarah
Stokes, Jonathan
Mazar, Iyar
Arenson, Ethan
Aiudi, Anthony
Wirth, R. J.
Houts, Carrie
-
Funding
Funding for this research was provided by:
Stealth BioTherapeutics
- License Information
-
More Information
Article History
Received: 5 December 2024
Accepted: 21 March 2025
First Online: 25 April 2025
Declarations
:
: The TAZPOWER trial protocol was approved by the Johns Hopkins University School of Medicine Investigational Review Board and the study was performed in accordance with the principles of the Declaration of Helsinki and with the standards of good clinical practice. Written informed consent was obtained from patients and/or their parent/guardian. Clinicaltrials.gov registration number NCT03098797.
: Not applicable. This manuscript does not contain data from any individual person.
: CG has received consulting fees from Stealth BioTherapeutics.
